SpectaCell is a biotechnology company that provides a next-generation potency testing platform for cell therapies
SpectaCell has raised $6.7M in total funding. The most recent round was Seed. The last funding was announced in October 2026.
SpectaCell's investors include imec.xpand, InnovationQuarter, PMV, VIB, QBIC II.
SpectaCell is headquartered in Ghent, Belgium.
SpectaCell is a biotechnology company that provides a next-generation potency testing platform for cell therapies
SpectaCell is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SpectaCell — Funding & Investors." VCBacked, October 8, 2026, https://www.vcbacked.co/company/spectacell. Accessed November 1, 2026.
VCBacked. (2026). SpectaCell — Funding & Investors. Retrieved November 1, 2026, from https://www.vcbacked.co/company/spectacell
{{cite web |title=SpectaCell — Funding & Investors |url=https://www.vcbacked.co/company/spectacell |website=VCBacked |access-date=November 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated